Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial
Authors
Keywords
Breast cancer, Bisphosphonates, Zoledronate, Disseminated tumor cells, Survival
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-10-16
DOI
10.1186/1471-2407-13-480
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How Do Bisphosphonates Inhibit Bone Metastasis In Vivo
- (2015) Pierrick G. Fournier et al. NEOPLASIA
- Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients
- (2012) E.- F. Solomayer et al. ANNALS OF ONCOLOGY
- Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer
- (2011) M. Gallo et al. ANNALS OF ONCOLOGY
- Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast
- (2011) Malgorzata Banys et al. BREAST CANCER RESEARCH AND TREATMENT
- The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer
- (2011) Malgorzata Banys et al. BREAST CANCER RESEARCH AND TREATMENT
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
- (2010) H. Eidtmann et al. ANNALS OF ONCOLOGY
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
- (2010) Rebecca Aft et al. LANCET ONCOLOGY
- Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer
- (2009) F.-C. Bidard et al. ANNALS OF ONCOLOGY
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer
- (2008) Bent Kristensen et al. ACTA ONCOLOGICA
- Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow--a long-term follow-up
- (2008) I. J. Diel et al. ANNALS OF ONCOLOGY
- Exploring the anti-tumour activity of bisphosphonates in early breast cancer
- (2008) M.C. Winter et al. CANCER TREATMENT REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started